(NASDAQ: ANIK) Anika Therapeutics's forecast annual revenue growth rate of 12.68% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.24%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Anika Therapeutics's revenue in 2025 is $91,850,000.On average, 2 Wall Street analysts forecast ANIK's revenue for 2025 to be $1,604,661,327, with the lowest ANIK revenue forecast at $1,598,822,000, and the highest ANIK revenue forecast at $1,610,500,653. On average, 2 Wall Street analysts forecast ANIK's revenue for 2026 to be $1,678,049,405, with the lowest ANIK revenue forecast at $1,672,065,897, and the highest ANIK revenue forecast at $1,684,032,912.
In 2027, ANIK is forecast to generate $1,763,620,769 in revenue, with the lowest revenue forecast at $1,763,620,769 and the highest revenue forecast at $1,763,620,769.